Cite

HARVARD Citation

    Terpos, E. et al. (n.d.). P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY. HemaSphere. p. 20. [Online]. 
  
Back to record